• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶、胰凝乳蛋白酶和聚集的γ-球蛋白对人血小板膜蛋白的影响。

Effects of thrombin, chymotrypsin and aggregated gamma-globulins on the proteins of the human platelet membrane.

作者信息

Podolsak B

出版信息

Thromb Haemost. 1977 Jun 30;37(3):396-406.

PMID:70080
Abstract

Analysis of platelet membrane proteins and glycoproteins by SDS polyacrylamide gel electrophoresis was carried out before and after treatment with thrombin. Extended incubation with thrombin (in the presence of EDTA or adenosine, which inhibit aggregation) produced extensive changes in the bands observed. With incubation times of a few minutes however, the changes were restricted to a glycopeptide, GP IV (approx. 90,000 Daltons) and one or two polypeptides of low molecular weight, in particular polypeptide 16 (approx. 23,000 Daltons). At 0--3 degrees C only polypeptide 16 was still hydrolyzed. Chymotrypsin, which does not activate platelets, attacked glycopeptides I, II, III but no changes were apparent in GP IV and polypeptide 16. When chymotrypsin-treated platelets were further incubated with thrombin, only GP IV and one to two low molecular weight polypeptides, especially polypeptide 16, were affected. As polypeptide 16 appears to be an integral membrane component it is possible that it, either by itself or in combination with GP IV, represents the primary thrombin substrate involved in platelet activation. Aggregated IgG, which also activates platelets, does not modify the membrane glycoproteins but does change the low molecular weight region in particular band 16.

摘要

在用凝血酶处理前后,通过SDS聚丙烯酰胺凝胶电泳对血小板膜蛋白和糖蛋白进行了分析。在凝血酶长时间孵育(存在抑制聚集的EDTA或腺苷)后,观察到的条带发生了广泛变化。然而,孵育几分钟时,变化仅限于一种糖肽GP IV(约90,000道尔顿)和一两种低分子量多肽,特别是多肽16(约23,000道尔顿)。在0 - 3摄氏度时,只有多肽16仍被水解。不激活血小板的胰凝乳蛋白酶作用于糖肽I、II、III,但GP IV和多肽16没有明显变化。当用胰凝乳蛋白酶处理过的血小板再与凝血酶孵育时,只有GP IV和一两种低分子量多肽,特别是多肽16受到影响。由于多肽16似乎是一种完整的膜成分,因此有可能它本身或与GP IV结合,代表了参与血小板激活的主要凝血酶底物。同样能激活血小板的聚集IgG不会改变膜糖蛋白,但会改变特别是条带16的低分子量区域。

相似文献

1
Effects of thrombin, chymotrypsin and aggregated gamma-globulins on the proteins of the human platelet membrane.凝血酶、胰凝乳蛋白酶和聚集的γ-球蛋白对人血小板膜蛋白的影响。
Thromb Haemost. 1977 Jun 30;37(3):396-406.
2
Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion.与血小板活化相关的膜变化。凝血酶诱导的分泌后肌动蛋白在血小板表面的暴露。
J Clin Invest. 1980 Jul;66(1):1-9. doi: 10.1172/JCI109821.
3
Identification of human platelet membrane fibrinogen receptors by immunochemical techniques.通过免疫化学技术鉴定人血小板膜纤维蛋白原受体
Haematologia (Budap). 1984;17(3):387-98.
4
Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.凝血酶和凝血酶受体肽SFLLRN对经胰凝乳蛋白酶或粘质沙雷氏菌蛋白酶预处理的人血小板聚集及14C-5-羟色胺释放的对比作用。
Thromb Haemost. 1995 Jan;73(1):122-5.
5
Deaggregation of human platelets aggregated by thrombin.凝血酶诱导聚集的人血小板的解聚
Thromb Haemost. 1985 Feb 18;53(1):42-4.
6
Effect of neutral proteases from blood leukocytes on human platelets.血液白细胞中性蛋白酶对人血小板的作用。
Thromb Haemost. 1983 Dec 30;50(4):768-72.
7
Structure and function of platelet glycocalicin.血小板糖钙蛋白的结构与功能
Thromb Haemost. 1980 Feb 29;42(5):1673-8.
8
Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.对二磷酸腺苷刺激无反应的血小板的钙离子动员和纤维蛋白原结合
J Lab Clin Med. 1985 Aug;106(2):111-22.
9
Human gamma-thrombin: lack of correlation between a platelet functional response and glycoprotein V hydrolysis.
Thromb Haemost. 1987 Oct 28;58(3):915-20.
10
[Importance of the interaction of surface receptors with the cytoskeleton for platelet function].[表面受体与细胞骨架相互作用对血小板功能的重要性]
Acta Histochem Suppl. 1990;39:319-25.

引用本文的文献

1
Proteolytic susceptibility of platelet low density lipoprotein receptor.
Lipids. 1995 Oct;30(10):927-33. doi: 10.1007/BF02537484.
2
Isolation and characterization of the major oligosaccharide of human platelet membrane glycoprotein GPIb.人血小板膜糖蛋白GPIb主要寡糖的分离与鉴定
Biochem J. 1982 Jul 1;205(1):81-90. doi: 10.1042/bj2050081.
3
Human platelet glycoprotein IIIb binds to thrombospondin fragments bearing the C-terminal region, and/or the type I repeats (CSVTCG motif), but not to the N-terminal heparin-binding region.人血小板糖蛋白IIIb与带有C末端区域和/或I型重复序列(CSVTCG基序)的血小板反应蛋白片段结合,但不与N末端肝素结合区域结合。
Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):231-6. doi: 10.1042/bj2840231.
4
Deletion of the platelet-specific alloantigen PlA1 from platelets in Glanzmann's thrombasthenia.在Glanzmann血小板无力症中血小板特异性同种抗原PlA1从血小板上缺失。
J Clin Invest. 1978 May;61(5):1225-31. doi: 10.1172/JCI109038.